Professional Documents
Culture Documents
H3+
DIGITAL HOLTER RECORDER
USER MANUAL
Copyright 2005
by Mortara Instrument, Inc.
7865 N. 86th Street
Milwaukee, Wisconsin 53224
This document contains confidential information that belongs to Mortara Instrument, Inc.
No part of this document may be transmitted, reproduced, used, or disclosed outside of the
receiving organization without the express written consent of Mortara Instrument, Inc.
Mortara is a registered trademark of Mortara Instrument, Inc. H3+ and H-Scribe are
trademarks of Mortara Instrument, Inc.
Headquarters
Mortara Instrument, Inc.
7865 North 86th Street
Milwaukee, WI 53224
Tel:
414.354.1600
Tel:
800.231.7437
Fax:
414.354.4760
Internet: http://www.mortara.com
Europe Economic
Community Representative
Mortara Rangoni Europe, Srl
(European Headquarters, Italy)
Via Oradour 7
40016 S. Giorgio di Piano, BO
Tel:
+39.051.6654311
Fax:
+39.051.6651012
Service/Technical
Support Group
Mortara Instrument, Inc.
7865 North 86th Street
Milwaukee, WI 53224
Tel:
414.354.1600
Service: 888.MORTARA
(888.667.8272)
Fax:
414.354.4760
E-mail: techsupport@mortara.com
Sales Support/
Supplies & Accessories
Mortara Instrument, Inc.
7865 North 86th Street
Milwaukee, WI 53224
Tel:
414.354.1600
Fax:
414.354.4760
E-mail: sales@mortara.com
Mortara Instrument GmbH
(Germany)
Kaninenberghhe 50
45136 Essen
Tel:
+49.201.268311
Fax:
+49.201.268313
Mortara Instrument B.V.
(The Netherlands)
H. Dunantplein 6
3731 CL De Bilt
Postbus 131
3720 AC Bilthoven
Tel:
+31.30.2205050
Fax:
+31.30.2201531
NOTICES
Manufacturers Responsibility
Mortara Instrument, Inc., is responsible for the effects on safety and performance only if:
Assembly operations, extensions, readjustments, modifications or repairs are
carried out only by persons authorized by Mortara Instrument, Inc.
The device (H3+) is used in accordance with the instructions for use.
Responsibility of the Customer
The user of this product is responsible for ensuring the implementation of a
satisfactory maintenance schedule. Failure to do so may cause undue failure and
possible health hazards.
Equipment Identification
Mortara Instrument, Inc. equipment is identified by a serial and reference number on
the back of the device. Care should be taken so that these numbers are not defaced.
Copyright and Trademark Notices
This document contains information that is protected by copyright. All rights are
reserved. No part of this document may be photocopied, reproduced or translated
to another language without prior written consent of Mortara Instrument, Inc.
Other Important Information
The information in this document is subject to change without notice.
Mortara Instrument, Inc. makes no warranty of any kind with regard to this material
including, but not limited to, implied warranties of merchantability and fitness for a
particular purpose. Mortara Instrument, Inc. assumes no responsibility for any errors
or omissions that may appear in this document. Mortara Instrument Inc. makes no
commitment to update or to keep current the information contained in this document.
ii
WARRANTY INFORMATION
iii
iv
Warning
Caution
Note
Warning
Device (H3+) stores data reflecting a patients physiological condition and can be
downloaded to a properly equipped analysis system. The data, when reviewed by a
trained physician or clinician, can be useful in determining a diagnosis. However,
the data should not be used as a sole means for determining a patients diagnosis.
To maintain designed operator and patient safety, peripheral equipment and
accessories that can come in direct patient contact must be in compliance with UL
2601-1, IEC 601-1 and IEC 601-2-47.
To maintain designed operator and patient safety, only use parts and accessories
supplied with the device and available thorough Mortara Instrument, Inc.
To avoid the possibility of serious injury or death, do not come in contact with the
device or patient cable during patient defibrillation. Additionally, proper placement
of defibrillator paddles in relation to the electrodes is required to minimize harm to
the patient.
A possible explosion hazard does exist; therefore do not use the device in the
presence of flammable anesthetics.
Defibrillation protection is guaranteed only if a Mortara Instrument, Inc. Patient
Cable is used.
Simultaneous connection to other equipment may increase leakage current.
ECG electrodes could cause skin irritation and should be examined daily. It may
be necessary to replace electrodes if signs of irritation or inflammation occur.
Before attempting to use the device for clinical applications, the operator must read
and understand the contents of the User Manual and any documents accompanying
the device.
Caution
To prevent possible damage to the Enter button, do not use sharp or hard objects
to depress the button; use fingertips only.
Do not attempt to clean the device or patient cable by submerging into a liquid,
autoclaving or steam cleaning.
Wipe the exterior surface of the device and patient cable with a non-alcohol
sterilizing disinfectant; then dry with a clean cloth.
Conductive parts of the patient cable, electrodes and associated Type CF connections,
including the neutral conductor of the patient cable and electrode, should not come
into contact with other conductive parts, including earth ground.
The device and patient cable should be cleaned after each use.
Do not pull or stretch patient cables since this could result in mechanical and/or
electrical failures. Patient cables should be stored after forming them into a
loose loop.
No user serviceable parts are inside. Any modification to any part of this device is to
be performed by Mortara Instrument, Inc. service personnel only. Any unauthorized
modification of this device may alter defibrillation protection.
Environmental Conditions:
Operating Temperature:
Storage Temperature:
Relative Humidity:
Ambient Air Pressure:
vi
-0 to +45 C
-20 to +65 C
5 to 95%, non-condensing
700 to 1060 millibars
Note
Proper patient preparation is important prior to proper application of ECG electrodes
and operation of the device.
Patient cables should be checked for cracks or breakage prior to use.
Complete lead fail will cause a greater draw on battery power which may cause the
recording period to end early due to low battery voltage.
As defined by IEC 60601-1 and IEC 60601-2-47, this device is classified as follows:
- Internally powered
- Type CF defibrillator proof applied parts
- Ordinary equipment
- Not suitable for use in the presence of flammable anesthetics
- Continuous operation
The device conforms to the following standards:
IEC 601-1
General Requirements for Safety
IEC 601-2-47
Particular Requirements for Safety,
including Essential Performance
IEC 601-1-2
Electromagnetic Compatibility
ANSI/AAMI EC38
Ambulatory Electrocardiographs
93/42/EEC
Medical Device Directive
The H3+ is a UL classified device:
Medical Equipment
WITH RESPECT TO ELECTRIC SHOCK,FIRE AND
MECHANICAL HAZARDS ONLY IN ACCORDANCE WITH
UL2601-1, IEC60601-1, CAN/CSA C22.2 No. 601.1
AND IEC60601-2-47
5P35
vii
EQUIPMENT SYMBOLS
Symbol Delineation
Battery
viii
Reference Number
9293-036-50
9293-036-51
9293-037-50
25019-006-50
ix
Emissions Test
Compliance
RF Emissions
CISPR 11
Group 1
RF Emissions
CISPR 11
Class B
Harmonic
Emissions
IEC 61000-3-2
Not Applicable
Voltage fluctuations/
flicker emissions
IEC 61000-3-3
Not Applicable
Compliance
Compliance
Level
Electromagnetic Environment:
Guidance
Electrostatic
Discharge (ESD)
IEC 61000-4-2
+/- 6 kV contact
+/- 8 kV air
+/- 6 kV contact
+/- 8 kV air
Electrical Fast
transient/burst
IEC 61000-4-4
+/- 2 kV for
Not Applicable
power supply line
+/- 1 kV for
input/output lines
Surge
IEC 61000-4-5
+/- 1 kV
differential mode
+/- 2 kV
common mode
Voltage dips,
short interruptions
and voltage
variations on
power supply
input lines
IEC 61000-4-11
<5% UT
Not Applicable
(>95% dip in UT)
for 5 cycles
40% UT
(60% dip in UT)
for 0.5 cycle
Power frequency
(50./60 Hz)
magnetic field
3 A/m
Not Applicable
3 A/m
xi
Table X-3
Guidance and Manufacturers Declaration: Electromagnetic Immunity
The H3+ is intended for use in the electromagnetic environment specified below. The
customer or the user of the H3+ should assure that it is used in such an environment.
Emissions
Test
IEC 60601
Text Level
Compliance
Level
Electromagnetic Environment:
Guidance
Conducted RF
IEC 61000-4-6
3 Vrms
150 kHz to
80 MHz
3 Vrms
150 kHz to
80 MHz
Radiated RF
IEC 61000-4-3
3 Vrms
80 MHz to
2.5 GHz
3 Vrms
80 MHz to
2.5 GHz
a. Field strengths from fixed transmitters, such as base stations for radio (cellular/cordless) telephones and
land mobile radios, amateur radios, AM and FM radio broadcast and TV broadcast cannot be predicted
theoretically with accuracy. To assess the electromagnetic environment due to fixed RF transmitters, an
electromagnetic site survey should be considered. If the measured field strength in the location in which
the H3+ is used exceeds the applicable RF compliance level above, the H3+ should be observed to
verify normal operation. If abnormal performance is observed, additional measures may be necessary,
such as reorienting or relocating the H3+.
b. Over the frequency range 150 kHz to 80 MHz, field strengths should be less than [3] V/m.
xii
Table X-4
Recommended Separation Distances Between Portable and Mobile RF
Communications Equipment and the H3+.
The H3+ is intended for use in the electromagnetic environment in which radiated RF
disturbances are controlled. The customer or the user of the H3+ can help to prevent
electromagnetic interference by maintaining a minimum distance between portable and
mobile RF communications equipment (transmitters) and the H3+ as recommended
below, according to the maximum output power of the communications equipment.
Rated Maximum Output
Power of Transmitter W
0.01
0.1 m
0.2 m
0.1
0.4 m
0.7 m
2.3 m
1.2 m
10
4.0 m
7.0 m
100
12.0 m
23.0 m
For transmitters rated at a maximum output power not listed above, the recommended
separation distance d in meters (m) can be estimated using the equation applicable to
the frequency of the transmitter, where P is the maximum output power rating of the
transmitter in watts (W) according to the transmitter manufacturer.
NOTE 1: At 800 MHz, the separation distance for the higher
frequency range applies.
NOTE 2: These guidelines may not apply in all situations.
Electromagnetic propagation is affected by the absorption and
reflection from structures, objects, and people.
xiii
ivx
TABLE OF CONTENTS
INTRODUCTION SECTION 1
H3+ Overview . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1-1
Manual Purpose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1-1
Audience and Indications for Use . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1-1
Conventions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1-1
System Description . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1-2
H3+ with Patient Cable and Accessories . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1-3
Front View with LCD Display . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1-3
Bottom View with Enter Button . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1-3
H3+ in Carrying Case with Neck Cord or Belt Clip . . . . . . . . . . . . . . . . . . . . 1-3
Mortara Part Numbers/ H3+ Digital Recorder . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1-4
Mortara Specifications/ H3+ Digital Recorder . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1-5
OPERATION SECTION 2
Entering Patient ID and Setting the Date/Time . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2-1
Opening and Closing the Battery Door . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2-1
Attaching the Patient Cable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2-2
Patient Hook-Up . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2-2
Skin Preparation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2-2
Positioning the Electrodes for a 3-Channel Patient Cable . . . . . . . . . . . . . . . . . . . . . 2-3
Positioning the Electrodes for a 2-Channel Patient Cable . . . . . . . . . . . . . . . . . . . . . 2-4
Inserting the Battery . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2-5
Using the Enter Button . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2-6
Displaying ECG Leads . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2-7
Starting a Recording Session . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2-7
Entering (Optional) Diary Events . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2-8
Ending a Recording Session . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2-8
MAINTENANCE SECTION 3
Cleaning the H3+ and Patient Cable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3-1
Periodic Maintenance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3-1
Disposal of Waste Materials . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3-1
xv
xvi
INTRODUCTION
SECTION 1
H3+ Overview
Manual Purpose
The H3+ User Manual explains how to operate the H3+ Digital Holter Recorder.
It shows the user how to
Start and end a patient recording
Prepare device configurations
Audience and indications for use
This manual is written for clinical professionals who are expected to have a working
knowledge of medical procedures and terminology as required for monitoring
cardiac patients.
The H3+ is indicated for use in a clinical setting, by qualified medical professionals
only, for recording ECG data of patients requiring ambulatory (Holter) monitoring
of up to 48 hours. Such monitoring is most frequently used for the purpose of
prospective and retrospective cardiac data and arrhythmia analysis. Holter analysis
is appropriate for the indications below:
Evaluation of adult patients with symptoms suggesting arrhythmia.
Evaluation of adult patients with pacemakers
Reporting of time domain heart rate variability
Evaluation of a patients response after resuming occupational or
recreational activities (e.g., after M.I or cardiac surgery)
Evaluation of ECG documenting therapeutic interventions in individual
patients or groups of patients
Clinical and epidemiological research studies
Infant patient evaluation is limited to QRS detection only
Conventions
Keys, such as Enter, appear in bold Arial font.
Text on the LCD screen of the H3+ appears in regular Arial font.
1-1
SECTION 1
System Description
The H3+ Digital Recorder provides two or three channels of continuous ECG data
recorded over a 24-hour or 48-hour period. An LCD screen and Enter button allow
for checking the lead quality during patient hook-up and starting the recording.
The 3-Channel 5-wire patient cable records 24 hours of data and displays ECG leads
I, II and V during patient hook-up. The 2-Channel 5-wire patient cable records ECG
for up to 48 hours and displays Channel 1 and Channel 2 during patient hook-up.
Either patient cable can be used with the H3+ digital recorder.
During recording, the LCD will display R and the time of day as HH:MM:SS indicating
that the H3+ is in the recording mode. The Enter button can be used to enter event
markers in the patient record.
The H3+ Digital Recorder uses a single AAA alkaline battery and stores acquired
ECG data in internal memory. The recorded data will remain in memory until it has
been cleared by the clinician.
Stored ECG data will be downloaded for analysis to the H-Scribe Holter Analysis
System with a USB interface cable after the H3+ has been disconnected from the
patient cable. After the data is downloaded, the memory can then be cleared and
the H3+ is ready for use on the next patient.
1-2
SECTION 1
Patient Cable
Milwaukee, WI
5P35
USA
Medical Equipment
UL60601-1,IEC60601-1,
CAN/CSA C22.2 No. 601.1,
IEC60601-2-47
Model:
H3+
1-3
SECTION 1
Part Numbers
H3PLUS-XXX-XXXXX
25019-006-50
8348-003-50
8485-022-50
9293-036-50
9293-036-51
9293-037-50
9515-165-50-ENG
9503-165-01-ENG
9503-165-02-ENG
5004-008-51
9424-012-51
1-4
SECTION 1
Specifications
Instrument Type
Input Channels
Leads Acquired
Modified I, II and V or
Bipolar Channel 1 and Channel 2
Input Impedance
Input Dynamic
Electrode Offset Tolerance
Frequency Response
Special Functions
A/D Conversion
12-bit
Storage
Device Classification
Weight
Dimensions
Battery
1-5
SECTION 1
1-6
OPERATION
SECTION 2
To close the battery door, place the battery door on the H3+ as shown below and slide the
door in the opposite direction until the door snaps into place.
2-1
SECTION 2
Input Connector
Patient Hook-Up
Skin Preparation
Skin preparation is important to perform before electrode attachment to help insure
good signal quality when recording patient data. Poor skin to electrode contact may
cause noise or artifact to be included in the recording which can affect the analysis
of the ECG data. Low amplitude signals may also be the result of poor skin to
electrode contact.
To prepare the skin
1. Identify the (5) electrode sites on the torso by referring to the next section on
Positioning the Electrodes.
2. Remove any hair from the electrode sites using a razor.
3. Wipe oils from the electrode sites with an alcohol prep pad and wipe the skin dry
with gauze.
4. Remove any dead skin from the electrode sites with an abrasive cleaner. Two to
three moderate rubs at each site is sufficient.
When the electrode sites have been identified and prepped, apply an electrode to
each of the (5) sites. Secure each electrode by exerting slight pressure around the
outer edge and inner ring of the electrode.
Attach lead wires to the electrodes. Excess lead wire length may be formed into
stress loops and secured with tape to prevent any pulling on the electrodes.
2-2
SECTION 2
AAMI
IEC
RA
LA
RL
R
L
N
LL
V
F
C
IEC
R = Red
L = Yellow
N = Black
F = Green
C = White
R and L = Channel 1 is Bipolar lead I
R and F = Channel 2 is Bipolar lead II
C and R/L/F = Channel 3 is a
Unipolar Chest Lead
AAMI
RA = White
LA = Black
RL = Green
LL = Red
V = Brown
RA and LA = Channel 1 is Bipolar lead I
RA and LL = Channel 2 is Bipolar lead II
V and RA/LA/LL = Channel 3 is a
Unipolar Chest Lead
2-3
SECTION 2
1-
2-
Reference
2+
1+
Lead Colors
1 - = White
2 - = Black
Reference = Green
1+ = Red
2+ = Brown
1+ to 1 - = Channel 1
2+ to 2 - = Channel 2
11+
22+
Reference
2-4
SECTION 2
2-5
SECTION 2
Milwaukee, WI
5P35
USA
Medical Equipment
UL60601-1,IEC60601-1,
CAN/CSA C22.2 No. 601.1,
IEC60601-2-47
Model:
H3+
ID CONFIRMATION
2-6
SECTION 2
2-7
SECTION 2
2-8
MAINTENANCE
SECTION 3
Periodic Maintenance
Check the H3+ and patient cable everyday to be sure they are not damaged or broken.
3-1
Maintenance (Continued)
3-2
The following table describes error and lead fail messages and symbols that are displayed
on the H3+ Digital Holter Recorder LCD during power up, patient hook-up, recording
and during connection to the H-Scribe.
Table of Messages
Message
Description/Solution
Replace existing battery with a fully charged battery.
ID:XXXXXXXXXXX
XXXXXXXXXXXXXX
R
USB
RA
LA
LL
V
A combination of
RA//V
+1+2A combination of
1+/2-
A-1
APPENDIX A
The following system information log is provided for your convenience. You need
this information if the H3+ needs servicing. Be sure to update the information log
when your device has been serviced.
Record the model and serial number of all components, dates of removal, and/or
replacement of components, and the name of the vendor from whom the component
was purchased and/or installed.
In addition to having records of this information, the system information provides a
warranty record of when your device was placed in service.
Telephone Numbers:
Domestic: 800-231-7437
European: +39-51-6650-701
Sales Department: 800-231-7437
Service Department: 888-MORTARA
Product Information:
Name of Unit/Product: ___________________
Date of Purchase: ___/___/_____
Purchased Unit From: ___________________
Serial Number: __________________________
Software Version: ________________________
A-2
EC Declaration of Conformity
(Directive 93/42/EEC)
We,
Manufacturers Name:
Manufacturers Address:
H3+
Catalogue Number:
H3+AXX-XXXXX
(X designates alpha characters denoting system
configuration management codes important for postdistribution servicing)
Serial Number(s):
Domestic, International
Class:
Domestic, International
IIa
technical file (ref.H3+, ANNEX VII) to
demonstrate the conformity of the product,
including all applicable options, to the essential
requirements (ANNEX I),
the EC Certificate ANNEX II N0178/B2P3/1 for
approval of the quality system,
the ISO 13485 Certificate N 0178/13485/3 for
approval of the quality system.
Notified Body:
LNE/G-MED (N 0459)
33 Avenue du Gnral Leclerc, BP8,
92260 Fontenay-aux-Roses - France
M0238.061 Rev. 1
01-April-05